InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,577.02
(
0.18%
)
US TECH 100
19,857.20
(
0.05%
)
Dow Jones
39,603.52
(
0.58%
)
Brent Oil
85.99
(
-0.60%
)
Bitcoin
57,109.84
(
2.26%
)
Post# of 403105
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (2) Keep Next 10 Report Keyboard Shortcuts
Replies (2) Next 10 Prev Next

govorchin

Send PM Follow Ignore
Followers 31
Posts 5410
Boards Moderated 0
Alias Born 01/22/2006

govorchin

Re: petemantx post# 35030

Wednesday, 06/19/2013 1:48:53 PM

Wednesday, June 19, 2013 1:48:53 PM

Post# of 403105
quote " i can't discuss efficacy data" . goes on further "he is pleased with the data" next cohort efficacious dose". do you really think they go from nothing to efficacious dose? do you think they are doing p21 qpcr's for the heck of it? i don't. he considered number of cycles, nurses reports? and OTHER information. could that be serum markers and mri's.


also i would like it explained to me how kevetrin is non poisonous etc when the chemical name for it contains the word cyanide. but i am coming to the conclusion that non poisonous is the correct term since dr holden used it.

gov
Public Reply Private Reply New Post
Keep Last Read
Replies (2) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (2) Next 10 Prev Next
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Detailed Quote
Recent IPIX News
More IPIX News
InvestorsHub NewsWire

Glidelogic Corp. Becomes TikTok Shop Partner, Opening a New Chapter in E-commerce Services • GDLG • Jul 5, 2024 7:09 AM

Freedom Holdings Corporate Update; Announces Management Has Signed Letter of Intent • FHLD • Jul 3, 2024 9:00 AM

EWRC's 21 Moves Gaming Studios Moves to SONY Pictures Studios and Green Lights Development of a Third Upcoming Game • EWRC • Jul 2, 2024 8:00 AM

BNCM and DELEX Healthcare Group Announce Strategic Merger to Drive Expansion and Growth • BNCM • Jul 2, 2024 7:19 AM

NUBURU Announces Upcoming TV Interview Featuring CEO Brian Knaley on Fox Business, Bloomberg TV, and Newsmax TV as Sponsored Programming • BURU • Jul 1, 2024 1:57 PM

Mass Megawatts Announces $220,500 Debt Cancellation Agreement to Improve Financing and Sales of a New Product to be Announced on July 11 • MMMW • Jun 28, 2024 7:30 AM

Start posting your company's news
Only $200 per official company press release!